Owlstone Ltd
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Early Liver Disease Breath Detection (NCT05935488) | Owlstone Ltd | 2024-05-21 |
| DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis (NCT07035158) | Owlstone Ltd | 2024-05-10 |
| Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients (NCT06344117) | Owlstone Ltd | 2023-12-12 |
| Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2) (NCT06193239) | Owlstone Ltd | 2023-10-05 |
| Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution) (NCT05510674) | Owlstone Ltd | 2021-07-06 |
| Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study (NCT04508556) | Owlstone Ltd | 2020-09-30 |
| Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols (NCT04467112) | Owlstone Ltd | 2020-07-30 |
| PAN-study: Pan-Cancer Early Detection Study (PAN) (NCT03756597) | Owlstone Ltd | 2018-09-26 |
Track Owlstone Ltd automatically
Every clearance here is in the API, with alerts when new ones post.